Product NDC: | 0074-3368 |
Proprietary Name: | Biaxin |
Non Proprietary Name: | Clarithromycin |
Active Ingredient(s): | 250 mg/1 & nbsp; Clarithromycin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-3368 |
Labeler Name: | AbbVie Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050662 |
Marketing Category: | NDA |
Start Marketing Date: | 19911031 |
Package NDC: | 0074-3368-11 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0074-3368-11) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0074-3368-11 |
Proprietary Name | Biaxin |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0074-3368-11) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0074-3368 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clarithromycin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19911031 |
Marketing Category Name | NDA |
Labeler Name | AbbVie Inc. |
Substance Name | CLARITHROMYCIN |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |